Liu, Kai-Sheng <br/><br/>
The heat shock protein 90 inhibitor SNX-2112 inhibits B16 melanoma cell             growth in vitro and in vivo.  [electronic resource] 

 -  Oncology reports  Jun 2012 
 - 1904-10 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1791-2431 
<br/><br/><label>Standard No.: </label>10.3892/or.2012.1738  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>G1 Phase Cell Cycle Checkpoints--drug effects<br/>Glycogen Synthase Kinase 3--antagonists & inhibitors<br/>Glycogen Synthase Kinase 3 beta<br/>HSP90 Heat-Shock Proteins--antagonists & inhibitors<br/>Heterocyclic Compounds, 4 or More Rings--pharmacology<br/>I-kappa B Kinase--antagonists & inhibitors<br/>Melanoma, Experimental--drug therapy<br/>Mice<br/>Mice, Inbred C57BL<br/>Mitogen-Activated Protein Kinases--antagonists & inhibitors<br/>NF-kappa B--drug effects<br/>Proto-Oncogene Proteins c-akt--antagonists & inhibitors<br/>Xenograft Model Antitumor Assays